Dewey Steadman | Head of IR |
James Edgemond | CFO and Treasurer |
Martine Rothblatt | Chairman and CEO |
Michael Benkowitz | President and COO |
Leigh Peterson | VP, Product Development |
Chris Shibutani | Cowen |
Liana Moussatos | Wedbush Securities |
Jessica Fye | JPMorgan |
Hartaj Singh | Oppenheimer |
Thomas Deal | Credit Suisse |
Eun Yang | Jefferies |
Geoff Meacham | Bank of America |
Good morning and welcome to the United Therapeutics Corporation Fourth Quarter 2019 Earnings Call. My name is Kensey, and I will be your conference operator today. [Operator Instructions]
I will now turn the conference call over to Mr. Dewey Steadman, Head of Investor Relations at United Therapeutics.